Prot #1199.225: An Open-Label Extension Trial to Assess the Long Term Safety of Nintedanib in Patients with 'Systemic Sclerosis Associated Interstitial Lung Disease' (SSc-ILD)

Project: Research project

Project Details

StatusActive
Effective start/end date5/24/185/24/21

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1199.225)